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“All the knowledge I possess everyone else can acquire, but my heart is all my own” 
–  Johann Wolfgang von Goethe 
  
  
 
 
  
ABSTRACT 
Background: Cardiovascular interventions including open heart surgery using 
cardiopulmonary bypass (CPB) and coronary angiography may introduce air and particulate 
arterial embolism that may lead to tissue lesions of the brain and other organs. 
Aims: To assess: if CO2-insufflation of an empty CPB circuit decreases number of gaseous 
emboli in the prime compared with a conventional CPB circuit, which holds air before fluid 
priming (Study I); the efficacy of a new mini-diffuser device for CO2 de-airing in a 
minimally invasive open cardiothoracic wound cavity model and in patients undergoing 
minimally invasive open aortic valve surgery (Study II); if an extra separate venous reservoir 
abolishes CO2-insufflation induced hypercapnia and retains sweep gas flow of the oxygenator 
constant during open heart surgery (Study III); if there is a difference in the incidence of 
cerebral microemboli when using either the femoral or the radial approach during coronary 
angiography (Study IV).  
Methods: Study I-II were experimental. Study I: Number of gaseous microemboli in the 
arterial line were counted after randomization to insufflation with CO2-gas or not prior to 
priming in 20 CPB-circuits. Study II: Air displacement efficacy of a mini-diffuser and of an 
open-ended tube was measured during CO2-insufflation in a minimally invasive open 
cardiothoracic wound cavity model and in patients undergoing minimally invasive open 
aortic valve surgery. Study III: A separate reservoir was used during CPB in addition to a 
standard venous reservoir. The separate reservoir received drained blood and CO2-gas 
continuously via a suction drain (1 L/min) and handheld suction devices from the surgical 
wound. CO2-gas was insufflated via a gas-diffuser in the open wound at 10 L/min. In a cross-
over design for each patient, gas and blood were either uninterruptedly drained from the 
separate to the standard venous reservoir or not. PaCO2 was determined after tuning of 
sweep-gas flow as necessary and following steady state of PaCO2 with an online monitor. 
Study IV: We randomized 51 patients to either right femoral or right radial arterial approach 
and documented with transcranial Doppler the number of particulate microemboli circulating 
through the middle cerebral arteries. 
Results: Study I. Throughout the experiment, the median microembolic count per minute in 
the CO2 group stayed lower than in the control group (p≤0.004). Study II. The air content 
was <1% and 10-75% in the open wound model during CO2 inflow of 2–10 L/min with the 
mini diffuser and the open-ended tube, respectively. In 6 patients air content in the open 
surgical wound stayed <1% during CO2 flows of 5 and 8 L/min via the mini-diffuser. Study 
III. Median PaCO2 did not vary between setups (5.41; 5.29-5.57, interquartile range [IQR] 
vs. 5.41; 5.24-5.58, p=0.92), while sweep-gas flow (L/min) was lower (2.58; 2.50-3.16 vs. 
4.42; 4.00-5.40, p=0.002) when CO2-gas was not drained from the separate to the standard 
reservoir. Study IV. The median (range) number of particulate emboli was significantly 
higher with radial 10 (1–120) than with femoral 6 (1–19) approach. Also, with the radial 
approach more particulate microemboli circulated through the right sided middle cerebral 
artery compared with the femoral approach. 
Conclusions: CO2-insufflation of an empty CPB circuit reduces the number of gaseous 
emboli in the prime compared with conventional CPB circuit priming (Study I); CO2 de-
airing with the mini-diffuser was effective in a minimally invasive open cardiothoracic 
wound cavity model and in patients (Study II); A separate venous reservoir, with a clamped 
connecting tube to the standard venous reservoir for evacuation of gas and blood from the 
open surgical wound, prevents CO2-insufflation induced hypercapnia in open heart surgery, 
keeping PaCO2 and sweep gas flow constant (Study III); When performing coronary 
angiography, the radial access produces a higher number of particulate cerebral microemboli 
than the femoral alternative (Study IV). This approach is hence advocated in this aspect. 
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1 INTRODUCTION AND BACKGROUND 
1.1 CLINICAL MANIFESTATION OF MACRO- VERSUS MICROEMBOLISM  
1.1.1 Macroembolism in cardiac surgery and during angiography 
In open heart valvular surgery there is a high risk of perioperative stroke, mostly considered 
to be due to macro-particulate and air embolization.[1] Bucerius et al. reported in a 
prospective study involving approximately 16,000 cardiac surgery patients, with a mean 
follow-up time of 11.7 days, that the risk of stroke was 4.8%, 8.8%, and 9.7 after isolated 
aortic valve replacement (AVR), mitral valve replacement (MVR), and multivalve surgery, 
respectively.[1] In contrast to cardiac surgery, the incidence of procedure-related stroke or 
TIA after coronary angiography and percutaneous coronary intervention (PCI) is very low, < 
0.3%.[2] 
1.1.2 Microembolism in cardiac surgery and during coronary 
angiography 
Cerebral microemboli may be detected with the transcranial Doppler (TCD) technique, both 
during open cardiac surgery [3] and during catheter-based cardiac procedures.[4-6] The great 
risks of cerebral microemboli in open heart surgery imply, as highlighted by a Cochrane 
review, that the number cerebral microemboli correlates with the quantity of postoperative 
neuropsychological disturbance.[7]  
The content in cerebral microemboli varies and may consist of air or particulate material 
including fat emboli, atheromatous debris or blood clots.[8] Microemboli have been 
associated with ischemic lesions detected with cerebral magnet resonance imaging (MRI).[4, 
9] Silent cerebral infarctions without overt clinical signs of stroke may give subtle 
neurological symptoms including signs of depression, minor visual defects and frailty.[10] 
Though the clinical impact of microembolism is debated, silent ischemic lesions have been 
associated with neuropsychological impairment and augmented risk of dementia. [4, 10] 
1.2 AIR EMBOLISM 
Air consists mainly of nitrogen (N2, 78.1%),[11] and does not dissolve easily in blood. This is 
the reason why arterial air embolism may cause perfusion defects.[12] Air microemboli in 
blood create foreign surfaces, which start the formation of microthrombi,[13] activation of 
platelets and leukocytes, as well as changing the erythrocyte count. [13-15] These gas-liquid 
interfaces of air microemboli in blood will also initiate adsorption and denaturation of 
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proteins in plasma.[13, 14, 16] The first protein that is layered on an air bubble surface is 
fibrinogen, which has non-polar hydrophilic parts that may act as binding sites for various 
blood-borne elements, including fatty acids [16] and lipid particles. These particles may 
stimulate platelet adhesion and aggregation.[17] Platelets that are activated via air 
microemboli get a similar structural change as when activated by collagen or thrombin.[18] 
Air microemboli instantly affect the vascular endothelium, causing functional changes, and 
also promote aggregation as well as activation of platelets and leukocytes.[19-24] The 
subsequent changes in microvascular permeability are the result of the release of 
inflammatory factors from activated cells, involving prostaglandins, leukotrienes, and 
thromboxanes.[25, 26] Arterioles having an inner diameter < 30 - 60 µm usually get 
obstructed by air microemboli. Even an air micro-embolus with a diameter of 25 µm that 
obstructs a cerebral arteriole for < 30 seconds will disturb brain function.[27] In a clinical 
study by Kirmani et al., evaluating number of arterial air microemboli, postoperative 
cognitive impairment has directly been linked with the number of perfusionists´ interventions 
during cardiopulmonary bypass (CPB).[7] Moreover, arterial air embolism during open heart 
procedures may produce various postoperative complications in different organs, e.g. cerebral 
injury, arrhythmias, and myocardial dysfunction.[28-34] 
1.2.1 Air micro-embolism in cardiac surgery 
In cardiac surgery air embolism may cause cerebral and peripheral organ dysfunction. When 
the heart or the large vessels are opened during cardiac surgery, air will enter the heart and 
the large vessels. Also, air emboli may already enter the arterial bed at the initiation of CPB. 
During CPB, microemboli have been causally related to several perioperative neurological 
complications. In this setting, one should not forget that the brain is particularly susceptible to 
ischemia caused by emboli. Postoperative neuropsychological impairment is seen in 30-80% 
of patients undergoing cardiac surgery using CPB and these pathological deficiencies may 
even advance and persist.[35]  
Even when conventional de-airing techniques are used in open heart surgery, many arterial 
air microemboli will nevertheless appear, particularly when the patient is weaned from 
CPB.[3, 36]  
1.2.2 Prevention of air micro-embolism in cardiac surgery 
Microembolic events occur when using CPB, despite use of new technologies, including 
microporous membrane oxygenators, better-quality arterial line filters, and CPB surface 
coatings, which all have been documented to reduce the amount of microemboli.[3]  
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1.2.2.1 Insufflation of CO2-gas in the open surgical wound 
Since the 1950s, many cardiac centers routinely insufflate the open cardiothoracic wound 
cavity with CO2-gas during surgery to prevent air from getting into the circulation. As the 
density of CO2-gas is 50% higher than air, CO2-gas will fill and displace air by gravity from 
the open wound cavity. Specifically, the density of CO2-gas is heavier than air as the 
molecular mass CO2 is 44 (12 + 2 x 16 = 44), which should be compared with that of the 
average molecular mass of air, which is 29 (80% N2 + 20% O2 = 0.8 x 28 + 0.2 x 32 = 29). 
Thus, the relation in molecular mass is 44/29 = 1.5 i.e. CO2 has a mass that is approximately 
50% higher. As CO2-gas is > 25 times more soluble in blood than air at 37 – 38 °C,[37, 38] 
arteriole obstruction or flow disturbance of the brain and other organs is believed to be 
reduced if blocked by CO2-gas.[39] Arterial CO2-emboli are much quicker resolved in blood 
and much better tolerated than air emboli.[29-32, 40, 41] As indicated in earlier studies, CO2-
gas cannot due to turbulence effectively de-air an open wound cavity if insufflated via an 
open tube or other devises unless a high flow-low velocity device is applied, i.e. a gas-
diffuser.[42-44]  
De-airing with CO2-gas insufflation in minimally invasive open heart surgery is extra critical 
compared with conventional open heart surgery via a full sternotomy, as the former 
procedure does not allow ordinary de-airing maneuvers. Besides, the much smaller wound 
cavity in minimally invasive open heart surgery, necessitates a considerably tinier device for 
CO2-gas insufflation. Until now, no device has been assessed for this purpose. 
CO2-gas evacuated from the open surgical wound cavity with a coronary suction device into 
the venous reservoir of the CPB circuit affects PaCO2 of the patient due to the large interface 
between blood and gas, where CO2-gas will dissolve in the continuous venous blood stream. 
Ventilation of the patient via the oxygenator in the CPB circuit must then be increased to 
maintain an approximately normal PaCO2 of 5.3 kPa, normal range 4.6 – 6 kPa (40 mmHg, 
normal range 35-45mmHg). If CO2-gas from the wound cavity may be separated from the 
standard venous reservoir, there should be no impact of the CO2-gas on the patient´s PaCO2. 
This would avoid CO2 induced hyperperfusion of the brain and thus decrease the risk of 
cerebral embolization during CO2-insufflation for de-airing in open heart surgery. 
1.2.2.2 Insufflation of CO2-gas in the CPB circuit 
Previous reports have identified when cerebral emboli appear during cardiac surgery, e.g. 
when the aortic cross-clamp is removed, and especially during weaning from CPB,[3] and 
how these may be prevented. However, only a limited number of studies have focused on 
microembolism when CPB is initiated. A prerequisite to decrease these microemboli is the 
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understanding of how the CPB circuit is built and primed. The components of the standard 
CPB circuit comprise an oxygenator (with or without an integrated venous and/or cardiotomy 
reservoir), a cardioplegia delivery set and an arterial filter, Figure 1.  
 
 
FIGURE 1. This figure illustrates the conventional parts of the extra-corporeal circuit. The color blue 
represents venous desaturated and hypercapnic blood. The color red illustrates arterial blood fully 
saturated with oxygen. The green and yellow colors represent blood from the aortic root and/or left 
ventricle and/or the lowest part of the open surgical wound cavity, which is emptied via suction devices to 
the venous cardiotomy reservoir” (re-printed with permission from Gunilla Kjellberg). 
 
A venous cannula is conventionally used to passively drain venous blood from the right 
atrium to a cardiotomy reservoir. Alternatively, a venous cannula is positioned in the superior 
and inferior caval vein, respectively, and joined to one tube via a Y-connector. The venous 
blood is then transported from the cardiotomy reservoir via a roller or a centrifugal pump past 
an oxygenator. When passing the oxygenator, CO2 is removed, and the venous blood gets 
saturated with oxygen. The oxygenator’s sweep gas flow rate and the oxygen concentration 
regulate the oxygen tension and saturation and CO2 pressure in the outgoing arterial blood. A 
heater/cooler system connected to the oxygenator controls the temperature of passing blood. 
The outgoing oxygenated arterial blood reenters the patient by an arterial cannula, which 
usually is positioned in the distal part of the ascending aorta. Blood passing the CPB circuit 
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will have contact with tubes and the main pump, as well as with additional pumps and tubes 
that drain blood from the surgical wound cavity to the venous reservoir. Totally, blood gets in 
contact with a foreign surface area of approximately 2 - 3 m2. The pump flow rate is usually 
2.4 L/m2/minute but will be adjusted to several factors including the patient´s body surface 
area, hematocrit and temperature.  
1.2.2.3 Traditional de-airing maneuvers of the CPB circuit 
The CPB circuit contains sterile air prior to priming with fluids. After all parts of the CPB 
circuit have been filled with prime fluid, the circuit will be re-circulated with the prime for 
several minutes. Additionally, to release trapped air, the perfusionist usually taps on the CPB 
circuit with a rubber hammer or a metal clamp. The knocking is typically sustained until the 
perfusionist confirms that the prime of the CPB circuit is well de-aired using a bubble sensor. 
This sensor is an integrated part of most CPB circuits and will usually detect single bubbles 
with a diameter of ≥ 300 µm (Stöckert S3, Sorin Group, Munich, Germany). To further 
efficiently evacuate air from the CPB circuit, perfusionists may insufflate the CPB circuit 
with CO2-gas prior to prime filling. However, studies evaluating this potentially important 
measure are missing.  
1.2.3 Air and particulate microembolism in coronary angiography 
The frequency of silent brain infarctions may be substantially higher than overt strokes during 
and early after coronary angiography[28] and microemboli have been observed passing the 
middle cerebral arteries (MCAs) during coronary angiography.[29] Current studies with 
diffusion weighted magnetic resonance imaging (MRI) indicate that microemboli may be the 
source of asymptomatic ischemic cerebral defects, but their clinical relevance is 
debatable.[30-32] 
1.2.3.1 Femoral versus radial access for coronary angiography 
There are several advantages of using the radial artery access such as the superficial anatomic 
position that allows easy compression, no important close structures, shorter duration of 
immobilization, and less periprocedural distress. All these factors may explain why this 
approach is preferred by patients.[45, 46] Women have smaller radial arteries than men, 
which may clarify why radial arteries in women are more likely to spasm. The spasm 
complication is a major reason of failure to perform coronary angiography via the radial 
access.[47, 48]. Also, the small artery size in women may restrict the use of larger 
interventional devices.[49, 50] 
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Various analyses comparing the radial and femoral access for cardiac catheterizations in 
terms of clinical outcome has been made. The first meta-analysis[51] found considerably 
fewer complications related to access site when comparing the radial with the femoral 
approach, but the hazard of major adverse cardiac events (MACE) did not differ. A following 
larger meta-analysis showed that the radial approach led to fewer major bleedings, although 
not effecting the combined endpoint of death, myocardial infarction (MI) and stroke.[52] A 
later meta-analysis that combined randomized clinical trials (RCTs) and observational studies 
including more than 750,000 patients, also found fewer major bleedings, nonetheless 
indicated a reduced mortality rate using the radial access.[53] 
The first large RCT comparing the two vascular approaches, the RIVAL trial, did not 
demonstrate a significant difference in the merged endpoint (death, stroke, MI, major 
bleeding). However, a subgroup analysis discovered that the radial access was beneficial for 
STEMI patients.[54] Two later RCTs, the RIFLE-STEACS and the STEMI-RADIAL, 
uncovered benefits for patients with ST-segment elevation in acute coronary syndrome using 
the radial approach regarding the composite outcome of cardiac death, MI, stroke, 
revascularization of the culprit lesion, and bleeding.[55, 56] A separate analysis of the 
composites of the combined endpoint showed that bleeding rates and cardiac mortality were 
significantly lower in the radial group of the RIFLE-STEACS trial only, and not in the 
STEMI-RADIAL trial.[55, 56] In the following MATRIX trial, the radial approach was 
linked with a lower rate of the merged endpoint (death, stroke, MI, and bleeding in acute 
coronary syndrome patients).[57]  
No significant differences in frequency of stroke was presented in the above mentioned 
RCTs, though they had a considerably higher incidence of stroke compared with register-
based incidences (0.3-0.7%).[54-57] However, when considering the low incidence of stroke 
or transient ischemic attack (TIA) related to the intervention, a type II error may be 
anticipated, as the RCTs were not adequately powered for this purpose. Besides, register 
studies may lack validity regarding stroke and TIA.  
In contrast to the low incidence rate of stroke and TIA, microemboli occur during most 
angiography procedures. This allows studies to be performed using a very limited number of 
patients.  In a non-randomized study by Spencer et al., cerebral microemboli appeared more 
frequently during coronary angiography using the radial than with the femoral approach.[32] 
Therefore, we designed the randomized Study IV to examine if the number of cerebral 
microemboli may differ between the radial and femoral approach during coronary 
angiography. 
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2 AIMS 
The specific aims were to: 
 
• evaluate if CO2-insufflation of an empty CPB circuit reduces number of gaseous 
emboli in the prime compared with a conventional CPB circuit, which contains air 
before fluid priming.  
 
• evaluate 1) a method to warrant a high content of CO2-gas (> 99%) in the empty CPB 
circuit, 2) if tapping on the oxygenator releases gaseous emboli, 3) if the duration of 
re-circulating the circuit with fluid prime has an impact on the number of gaseous 
emboli. 
 
• assess efficiency of a mini-diffuser device for CO2 de-airing in aminimally invasive 
open cardiothoracic wound cavity model with and without intermittent rough suction 
as well as in patients undergoingminimally invasive open aortic valve surgery. 
 
• evaluate if an additional separate venous reservoir eliminates CO2-insufflation 
induced hypercapnia and keeps sweep gas flow of the oxygenator constant during 
open heart surgery. 
 
• test if there is a difference in incidence of cerebral microemboli between the femoral 
and the radial access site during coronary angiography. 
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3 METHODS 
3.1 STUDY DESIGN AND PATIENT SELECTION 
The experimental randomized Study I was divided into two sections. In the first part, we 
developed a technique to confirm that the empty CPB circuit was totally filled with CO2-gas 
(> 99%). In the second part, we measured the amount of gaseous microemboli in the prime 
circulating in the CPB system. Prior to the beginning of each test, we randomized the CPB 
circuit to an interventional or a control group using unmarked envelopes.  
Study II consisted of laboratory tests followed by confirmation of the de-airing efficacy of 
the used device by point measurements of air content in an open minimally invasive surgical 
wound cavity and in six patients having AVR surgery.  
Study III (ClinicalTrials.gov Identifier: NCT04202575) included clinical measurements 
during CPB in 10 patients undergoing AVR with either coronary artery bypass grafting 
(CABG) or not, where the patients served as their own controls using a cross-over design.  
The clinical Study IV (ClinicalTrials.gov Identifier: NCT01428947) was a prospective, 
randomized, single-center trial. Three-hundred-forty patients were screened from February 
2007 to June 2008, whereof 51 were included and randomized to coronary angiography via 
either radial (n = 28) or femoral (n = 23) approach. All patients had stable angina pectoris and 
were planned for diagnostic coronary angiography. Exclusion criteria included valvular heart 
disease, previous CABG, a pathological Allen´s test (indicating absence of collateral arterial 
blood flow to the hand)[58] of the right hand, severe kidney disease with an estimated 
glomerular filtration rate (eGFR) less than 30 mL/min calculated with the Cockcroft-Gault 
formula, and if not blood flow velocity was measurable in both MCAs with TCD. 
Study I-IV were performed at the Karolinska University Hospital, Stockholm, Sweden.  
3.2 CLINICAL PRACTICE 
3.2.1 Cardiopulmonary bypass system 
In Study I we used a Stöckert S3 heart-lung machine, which consisted of a roller pump and a 
Dideco pre-mounted tubing set with Compactflo EVO adult Phisio-coated membrane 
oxygenator (Dideco, Sorin Group, SpA, Mirandola, Italy). The volume of the CPB system 
was 5.5 L. We primed the CPB system with 1500 mL Ringer´s Acetate, 250 mL Mannitol 
15% and 5,000 units of heparin. The temperature of the priming solutions was 20-22°C. We 
passively filled each CPB-circuit and attached the tubing of the pump house to the main 
pump. 
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In Study III we used a Stöckert S5 heart-lung machine and the CPB circuit set (Sorin 
Perfusion Tubing Systems, Sorin Group Italia S.r.l. Mirandola (MO), Italy) consisted of an 
oxygenator, a centrifugal pump and a standard venous reservoir was set up with an additional 
venous reservoir (Sorin Inspire HVR, Sorin Group Italia S.r.l. Mirandola (MO), Italy), to 
which the coronary suction device (suction rate of 0.25-1 L/min,) was connected as well as an 
extra cardiotomy suction device (suction rate 1 L/min), placed in the wound cavity 4 cm 
below the skin surface. The additional venous reservoir was positioned above and connected 
with a tube to the standard CPB cardiotomy reservoir. To enable blood sampling Luer lock 
connections were inserted in the CPB circuit; 1) at the venous return tubing before entrance to 
the standard venous reservoir, 2) between the standard venous reservoir and the oxygenator, 
and 3) on the arterial line of the circuit. An on-line device for blood gas analyses (CDI™ 500, 
Terumo Cardiovascular Systems Corporation, MI, USA), was connected to the arterial line 
between the oxygenator and the patient. The CPB system was primed with 1500 mL Ringer´s 
Acetate, 250 mL Mannitol 15% and 7,500 units of heparin. 
3.2.2  Angiography 
In Study IV, all patients were treated with aspirin prior to coronary angiography. During 
coronary angiography, the Seldinger technique was used by puncturing the vessel wall with a 
needle through which a flexible guidewire was pushed forward and left intravascularly as the 
needle was withdrawn, where after a sheath was advanced over the guidewire. The sheath 
was equipped with a valve and a side port for catheter placement and drug administration, 
respectively. For decades the femoral access has been the conventional  approach, for 
percutaneous coronary interventions, allowing the use of large sized catheters.[59] The 
common femoral artery was punctured 1-2 cm distal of the inguinal ligament. After flushing 
the catheter, a guidewire was inserted and advanced to the thoracic aorta. Currently, two 
catheterization techniques are used: either the guidewire is withdrawn in the descending aorta 
or catheters are advanced through the aortic arch by a guidewire. The latter technique is 
thought to minimize the risk of dislodging arteriosclerotic debris from the aortic arch. Local 
traditions decide preference to either technique but hard evidence regarding ischemic 
neurological complications is rare. After catheterization, the femoral arterial sheath was 
removed and to achieve hemostasis, vascular puncture site was either compressed manually 
or by a mechanical device (FemoStop®, Radi Medical systems, Uppsala, Sweden). 
Alternatively, the arterial puncture site was closed by insertion of a resorbable plug 
(AngioSeal®, St.Jude Medical), which reduces the duration for hemostasis.[60]  
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3.3 SPECIFIC DEVICES AND METHODS 
3.3.1 Measurement of air content 
In Study II, we based the size of the minimally invasive cardiothoracic wound model on 
measurements (median) of minimally invasive cardiothoracic wound cavities of 3 patients 
undergoing minimally invasive open heart procedure using an incomplete J-shaped 
sternotomy. The orifice of the wound model had a radius and a depth of 35 mm and 44 mm, 
respectively. Additionally, an aortic model measuring 50 x 40 x 40 mm was placed at its 
base. 
Air displacement in the experimental circuit, Study I, and in the experimental as well as 
patients´ minimally invasive wound cavities, Study II, was evaluated by measuring residual 
O2-gas concentration.  This was calculated to percentage of CO2-content using the simple 
method: %CO2 = [100 - (%O2 measured x 100 / %O2 initial)]. The O2-content was 
determined using an ceramic sensor (CheckMate 9900, PBI-Dansensor A/S, Ringsted, 
Denmark), with a gas sampling volume of < 2 mL, a response duration below 2 seconds (> 
20.95% change in bidirectional O2-concentration), a measurement range of 0.0001% - 100% 
O2, and a 1% accuracy of the measured value. A 1.5 mm thick Teflon tube was used as a 
sampling probe. The O2-concentration is approx. 1/5 of air, to be precise, 20.95% close to sea 
level.[11] Although air is a mixture of gases, including O2, air performs as one single gas at 
normal pressure and temperature. According to Avogadro’s law, “At constant pressure and 
temperature equal volumes of different gases contain equal amounts of gas molecules”. 
Consequently, for every 5 CO2-molecules insufflated to each measuring point, 5 air 
molecules will be moved and one of these 5 molecules will be an O2-molecule. Hence, by 
measuring the O2-content, the concentration of air and CO2-gas is given concomitantly. The 
O2-measuring device has a heated ceramic sensor that measures displacement of air more 
accurately than ordinarily used CO2-sensors that are based on an infrared sensor technique to 
measure CO2-concentrations up to 100%. The ceramic O2-sensor has in comparison a higher 
accuracy, requires less gas, and is quicker than standard CO2-sensors. 
3.3.2 Single channel microbubble Doppler detector 
In Study I we used a single channel microbubble Doppler detector (CMD-10, Hatteland 
Instrumentering, Royken, Norway), which was attached to the arterial line. The velocity 
range of the bubble detector was 2.5 - 5 m/s and measured bubbles sizing from around 10 - 
300 μm. The maximum counting rate was around 2000 microbubbles/min. A thirteen mm 
(3/8” I.D. tubing) conventional probe was connected to the arterial line. The CMD-10 was 
linked to a personal computer using the BubmonWv1.3 software to record number of 
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microemboli. The Hatteland CMD10 single-channel microbubble detector does not measure 
bubble sizes accurately.  
3.3.3 Multifrequency transcranial Doppler 
Study IV: The noninvasive TCD technique measures blood flow velocity in cerebral arteries 
using the Doppler effect. It is used clinically to discover and evaluate intracranial vasospasm 
in patients with subarachnoid hemorrhage, diagnose cerebrovascular ischemia (steno-
occlusive disease, acute ischemic stroke), assess intracranial arterio-venous malformations, 
cerebral microemboli, and cerebral perfusion after circulatory arrest.[61] 
An ultrasound probe positioned over the thinnest part of the temporal bone, the temporal 
window, emits waves that are transmitted through the skull and the frequency change of the 
reflected ultrasound waves are also registered by the probe and correspond to the velocity of 
the moving red blood cells within the insonated cerebral vessel (the Doppler shift frequency).  
Also, the direction of the blood flow can be detected. A 2 MHz frequency ultrasound probe 
was used for the TCD measurements, (Embodop®, DWL, Singen, Germany) including the 
identification of the intracranial carotid artery bifurcation, where after the MCA can be 
identified by having a blood flow direction towards the probe.[61, 62] 
Microemboli passing the insonated vessel deflect ultrasound waves, which return and are 
registered as high-intensity transient signals (HITS), Figure 2. The multifrequency technique 
allows automatic differentiation of gaseous and solid microemboli due to different 
backscatter profiles. Solid emboli reflect more intense ultrasound signals at the higher 
frequency, whereas gaseous microemboli reflect more intense signals at the lower 
frequency.[63-65] We used the power M-mode Doppler (PMD) that provides simultaneous 
flow signals by overlapping sample volumes that facilitates the “tracking” of the emboli.[66] 
Particulate as well as gaseous microemboli are registered as microembolic signals (MES). 
The cut-off level for detection of microemboli was set as a ³ 7 dB increase above the 
background level (delta embolus blood ratio [dEBR]) lasting ³ 4 ms concurrently in the 2.0- 
and the 2.5-MHz frequency channel, respectively. The patients´ MCAs were detected at a 
depth of 40 - 55 mm from the skin level at the temporal window. We used a sample volume 
of 13 mm, no filter, a power of 200 mW, and an 80 cm/s scale. To reject artifacts online a 
reference gate was set 15 mm superficially to the MCA insonation gate.  
TCD monitoring was continuously performed from the beginning of the sheath insertion and 
ended when the final catheter had been withdrawn and corresponded to predefined procedural 
steps during coronary angiography.[61, 63-65] 
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FIGURE 2.  Pulsating transcranial Doppler blood flow velocity signal including several high-intensity transient 
signals from the insonated middle cerebral artery. 
 
3.3.4 Devices for insufflation of CO2-gas 
3.3.4.1 Devices for insufflation of CO2-gas in minimally invasive open-heart surgery 
The CO2-diffuser (CarbonMini® Cardia Innovation AB, Stockholm, Sweden), a single-use 
insufflation device, consisting of three parts. A two meter long polyvinyl chloride (PVC) tube 
that has an inner diameter of ¼ inch (6.35 mm), a bacterial filter (ORO1H from Pall Medical, 
Portsmouth, U.K.), a 0.20 m PVC tube that has an inner diameter of 1 mm inside which a 
metal thread runs, and a cylindrical diffuser consisting of soft polyurethane, with a diameter 
of 7 mm and a length of 17 mm, and corresponding to a surface area of approximately 4 cm2, 
Figure 3. As a control device, we used a plastic tube with an inner diameter of 1 mm, that is 
frequently used for CO2-insufflation during minimally invasive open heart surgery. 
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FIGURE 3.  The mini CO2-diffuser (CarbonMini® Cardia Innovation AB, Stockholm, Sweden), is a single-use 
insufflation device that consists of three parts, a two m long PVC tube, a bacterial filter, a 0.20 m PVC tube that 
has an inner diameter of 1 mm inside which a metal thread runs, and a cylindrical diffuser consisting of soft 
polyurethane (approx. 4 cm2). 
3.3.4.2 Device for insufflation of CO2-gas in full sternotomy open heart surgery 
In Study III, de-airing of the open cardio-thoracic surgical wound cavity was performed 
before cannulation and continued using CO2-gas insufflation at 10 L/min via a CO2-diffusor 
(CarbonAid® Cardia Innovation AB, Stockholm, Sweden), Figure 4, until closure of the 
heart and aorta. We positioned the CO2-diffuser in the open surgical wound cavity at a depth 
of > 4 cm from the edge of the wound surface.  
 
 
FIGURE 4.  The standard CO2-diffuser (CarbonAid® Cardia Innovation AB, Stockholm, Sweden), a single-use 
insufflation device, which includes three parts, a two m long PVC tube, a bacterial filter, a 0.20 m PVC tube that 
has an inner diameter of 1 mm inside which a metal thread runs, and a cylindrical diffuser consisting of soft 
polyurethane (approx. 10 cm2). 
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3.3.5 Suction rate measurements 
Using a back-pressure compensated O2-flowmeter, the CO2-gas flow was determined, as 
CO2-flowmeters are seldom used clinically. The O2-reading scale was accustomed for CO2 
with a universal flowmeter (ABB/Fisher & Porter, Göttingen, Germany), due to the higher 
density of CO2-gas. The universal flowmeter comprised of a measuring tube (FP ¼ -16 G-
5/81) including a spherical stainless-steel float (SS-14). Nevertheless, we did not apply the 
universal flowmeter for direct quantifications in Study II, because of absence of 
compensation for back-pressure. During the calibration this disadvantage was circumvented 
by determining the CO2-outflow distal to the insufflation devices. The reading scale of the 
universal flowmeter was calibrated for medical CO2-gas (AGA Gas AB, Stockholm, Sweden) 
at 20 ºC and at 1013 mbar using a software (FlowSelect version 2.0, ABB/Fisher & Porter, 
Göttingen, Germany). We avoided the use of a coronary suction device during measurements. 
The suction rate of the rough suction device was 5, 10, and 15 L/min, respectively, 
determined with the help of a flowmeter. 
3.4 STUDY INTERVENTIONS 
Study I, an in vitro study, consisted of two parts. First, we developed a procedure to 
guarantee absolute filling of the empty CPB-system with CO2-gas (> 99%). Secondly, we 
measured the amount of microemboli passing through the circuit in the prime fluid. Ten CPB 
circuits were used in the first study part, with the aim to ensure that more than 99% of the 
inner volume of the CPB system contained CO2-gas. Figure 5 depicts the used CPB system, 
which was filled with CO2-gas from the highest part of the venous reservoir (A).  
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FIGURE 5.  The pictures summarize how Study I was setup. (A) corresponds to the inlet for CO2-gas and (B) 
represents the overpressure valve. The measuring points are situated at highest part of the venous reservoir 
(1), at the outflow of the oxygenator (2), and at the 3-way Luer lock where the samples from the shunt were 
taken (3). 
 
The CO2-gas was insufflated via a 0.2 μm bacterial filter at a flow rate of 10 L/min and the 
CO2-concentration was determined at 3 sites; The measuring points are situated at highest 
part of the venous reservoir (1), at the outflow of the oxygenator (2), and at the 3-way Luer 
lock where the samples from the shunt, between the arterial and venous tube, were taken (3). 
In order to evacuate surplus gas, we detached the overpressure peg-valve (B) situated on the 
highest part of the venous reservoir. The measurements at the above described 3 sites were 
performed during a period of ten minutes with one-minute intervals. We determined the CO2-
concentration at 3 locations, each site denoting an important part of a standard CPB circuit, 
which was not performed in the single previous report on this topic.[67] However, in that 
research paper the CPB system lacked a venous reservoir and the CO2 measurements were 
sampled in the same arterio-venous line, distal to the CO2-gas inlet. There was only a 40 μm 
arterial filter between those two measuring sites, and the total circuit volume was just 575 ml, 
around 10% of the volume applied in our study, when measured from the CO2-gas inlet point 
of the sampling port.  
In the following segment of Study I we used 20 CPB circuits. CPB-circuits were randomized 
to an intervention (n = 10) or a control group (n = 10), immediately before the start of each 
experiment using unmarked envelopes. In the intervention group, we insufflated each CPB 
system with CO2-gas at the highest point of the venous reservoir for 5 minutes, see above. 
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Thereafter, the CPB-system was filled slowly with priming fluid during continuous CO2-gas 
insufflation. In the control group we abstained from filling the CPB systems with CO2-gas, 
whereby the CPB-circuits only held air. After stopping CO2-gas insufflation in the 
intervention group, a perfusionist blinded to group assignment set the flow rate of the main 
pump to 5 L/min and the 100% O2-sweep gas flow of the oxygenator to 3 L/min, 
respectively. Subsequently, during the first minute, the perfusionist knocked on the 
oxygenator 20 times with an arterial line cross-clamp. Next, the whole CPB system was 
running without any intervention for 12 minutes. During the 14th minute the perfusionist once 
more tapped 20 times on the oxygenator. Number of microemboli were counted till the 15th 
minute had passed. 
Study II: We placed the distal end of the mini-diffuser pointing to the base of the 
experimental surgical wound cavity at a depth of 25 mm, measured from the edge of the 
wound opening. CO2-gas was insufflated in the wound cavity via the mini-diffuser at 2, 3, 4, 
5, and 10 L/min, respectively. The air concentration of the experimental wound cavity was 
determined during steady state in each quadrant, 15 mm below the edge of the wound 
opening and at the bottom of the wound cavity. The de-airing efficacy of the mini-diffuser 
and the control 1 mm open-ended tube, respectively, was measured during fixed settings 
without involvement of suction devices. Thereafter, the efficacy of the mini-diffuser was 
additionally tested with different suction rates, using a suction device (Kendall Argyle 
Yankauer suction tube (fine), Tyco Healthcare, 4.0 mm, Ireland) during and after a 2 second 
suction period, or during uninterrupted suction at 15 mm beneath the edge of the wound 
orifice. The O2-concentration was determined 40 mm below the wound area opening at 
steady state, i.e. 60 seconds of stable values, prior to start of intermittent (2 s) or 
uninterrupted suction, with ten measurements under each condition. Following initiation of 
intermittent suction, the O2-concentration was determined every 5 seconds for 25 seconds. 
Following initiation of uninterrupted suction, the O2- concentration was determined every ten 
seconds for ninety seconds. Residual CO2-gas in the cavity was evacuated via a rough suction 
device prior to each alteration in CO2-flow rate, insufflation device, or measuring site. In 6 
patients undergoing minimally invasive AVR via a six cm J-shaped partial sternotomy, from 
the cranial part of the manubrium to the 3rd intercostal space, air concentration was 
determined four cm beneath the edge of the wound opening, when insufflating the open 
surgical wound cavity at a CO2-flow of 5 and 8 L/min, respectively, with a mini-diffuser, 
positioned contra-lateral to the site of measurement. 
In Study III, a CPB circuit set (Sorin Perfusion Tubing Systems, Sorin Group Italia S.r.l. 
Mirandola (MO), Italy) consisting of an oxygenator, a centrifugal pump and a standard 
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venous reservoir was set up with an additional venous reservoir (Sorin Inspire HVR, Sorin 
Group Italia S.r.l. Mirandola (MO), Italy), to which the coronary suction device (suction rate 
of 0.25-1 L/min,) was connected as well as an extra cardiotomy suction device (suction rate 1 
L/min), placed in the wound cavity 4 cm below the skin surface. The additional venous 
reservoir was positioned above and connected with a tube to the standard CPB cardiotomy 
reservoir. To enable blood sampling Luer lock connections were inserted in the CPB circuit; 
1) at the venous return tubing before entrance to the standard venous reservoir, 2) between 
the standard venous reservoir and the oxygenator, and 3) on the arterial line of the circuit. An 
on-line device for blood gas analyses (CDI™ 500, Terumo Cardiovascular Systems 
Corporation, MI, USA), was attached to the arterial line. During CPB with standard 
configuration, the conventional setup, blood as well as gas from both the coronary and 
cardiotomy suction devices were without interruption drained through the separate reservoir 
to the conventional reservoir. During the intervention setup the line connecting the separate 
and conventional venous reservoir was closed with a clamp. Accordingly, drained blood and 
gas from the coronary and cardiotomy suction devices stayed in the separate venous 
reservoir. If the blood volume in the separate venous reservoir exceeded 800 ml it was 
drained to the conventional reservoir, leaving at least 100 ml of blood in the separate venous 
reservoir to avoid spillover of CO2-gas.  
The patients were treated according to routine before clamping of the aorta, including venous 
and arterial cannulation of the right atrium and the ascending aorta, respectively. De-airing of 
the open surgical wound was initiated before cannulation and continued using CO2-gas 
insufflation of 10 L/min via CO2-diffusor (CarbonAid® Cardia Innovation AB, Stockholm, 
Sweden) until closure of the heart and aorta. A recent study by independent authors found the 
device used in our study, the CarbonAid® diffuser, to be superior to all other tested devices, 
delivering 100% CO2 concentration in the tested surgical cavity with CO2-gas insufflation 
rates of 7 - 10 L/min.[44] We positioned the CO2-diffuser in the open surgical wound cavity 
more than 4 cm below the edge of the wound. The perfusionist adjusted the sweep gas flow 
of the oxygenator aiming to keep a PaCO2 of approximately 5.3 kPa by following the on-line 
arterial gas data (CDI™ 500). Five minutes after arterial blood gas steady state was reached 
in either setup, blood gas samples were drawn from the three sample points (see above) and 
measured with a conventional blood gas analyzer (ABL 825 Flex, Radiometer Medical ApS, 
Brønshøj, Denmark). Using a crossover design, the setup was switched as many times as 
possible, ranging between 2 and 6 times (median 4) for each patient between the 
interventional and the conventional setup and the mean values from the three sampling 
points for each setup for each patient were used for comparison between patients. 
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TABLE 1. Predefined parts of the coronary angiography 
Stages Practical implementation  
1. Arterial access  Insertion and flushing of introducer   
2. Insertion of first catheter  Insertion of guidewire*  
Insertion of catheter  
Removal of guidewire  
Withdrawal of blood and flushing of catheter   
3. Coronary angiography  Engagement of coronary ostium  
Contrast injection   
4. Exchange of catheters  Disengagement of catheter  
Introduction of guidewire  
Removal of first catheter  
Insertion of new catheter  
Removal of guidewire  
Withdrawal of blood and flushing of catheter   
5. Coronary angiography  Engagement of coronary ostium  
Contrast injection   
6. Removal of guidewire and catheter  Disengagement of catheter  
Introduction of guidewire  
Removal of guidewire and the catheter   
(*) with the femoral access technique, guidewire and catheter were inserted together  
 
Study IV. Following randomization to radial or femoral approach, the coronary angiography 
process was separated into six predefined parts reflecting catheter swap and engagement of 
coronary ostia, Table 1. Coronary angiography was performed by two interventional 
cardiologists using selective catheters for the right and the left coronary artery, respectively. 
When using the radial access, a pharmacological mix consisting of 250 µg glycerylnitrate, 
5000 units of Heparin, and 2.5 mg verapamil hydrochloridium in 15 ml of 0.9% saline, was 
injected into the 6 French Flexor Radial sheath (Cook, Denmark). Directly after its insertion, 
the tip of the 6 French JL 3.5 and JR 4 catheter (Boston Scientific), respectively, was 
positioned in the Valsalva sinus and substituted over a 0.035” 250 cm guide wire (Cordis). 
Ultimum 6 French sheaths (St. Jude Medical) were used to access the femoral artery, and 6 
French JL and JR 4 catheters (Boston Scientific) and 0.035” 150 cm guide wires (Boston 
Scientific) were inserted into the ascending aorta. All catheters and guide wires were 
heparinized before use. Every patient received the standard contrast medium, Visipaque 320 
mg/mL (GE Healthcare). Duration of fluoroscopy and volume of injected contrast were 
recorded.  Simultaneously, we recorded the amount of passing cerebral microemboli the 
MCAs bilaterally with a multifrequency TCD system (Embodop, DWL). Using a 
synchronized clock, TCD measurements were correlated with the predefined parts of the 
coronary angiography procedure.   
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3.5 ETHICS 
The research papers in the thesis follow the principles of the Helsinki Declaration and the 
Regional Ethical Review Board in Stockholm endorsed the studies (Study II: 2015/323–32; 
Study III: 2018/1091–31; Study IV: 2006/1077-31/2). All included patients agreed to 
participate in the studies, Study II-IV.  
3.6 STATISTICS  
Study I-IV. Data were analyzed with SPSS® statistical program (http://www.spss.com). We 
considered a two-sided probability level of less than 0.05 as significant. 
Study I. The Kolmogorov-Smirnov analysis was applied to test for normality distribution of 
data. Otherwise, conventional non-parametric tests were used. We expressed results as 
median, with interquartile range (IQR).  
Study II. Data were described as mean ± standard deviation (SD). Due to the small numbers, 
we used the non-parametric Kruskal-Wallis and Mann-Whitney U-tests, which were used 
when appropriate. 
Study III. No power calculation was performed as there are no available data with this setup. 
We applied the paired Mann-Whitney U-test for comparison between groups, as there were 
few patients.  
Study IV. We used the Mann–Whitney U-test for continuous variables, and X2-test and 
Fisher’s exact test for categorical data. Based on data from Lund et al.[4] reporting a 40% 
decrease in number of particulate microemboli when using the  femoral (n = 10) compared 
with the radial (n = 37) artery access, approximately 22 patients were needed to find a 
significant difference between the two approaches with a power of 80%.
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4 RESULTS 
4.1 STUDY I 
According to Figure 6, CO2-gas insufflation into the CPB system caused a quick rise in CO2-
concentration at the 3 measuring sites reaching more than 99.00% within 4 minutes. Then, 
the mean values stabilized and barely augmented with centesimal of percentages for every 
additional minute. The measured data at the oxygenator (Site 2) were significantly lower 
compared with measured data at the venous reservoir and at the shunt (Site 1 and 3) for each 
time point.  
 
 
FIGURE 6. Mean CO2 (%) at 3 measuring sites during CO2-insufflation into the CPB circuit. 
 
Figure 7 shows median amount of microemboli for the groups for each minute throughout 
the experiment, which lasted 15 minutes. During the first minute, the median number of 
microemboli peaked in both the control and the intervention group, with 380.5 (IQR 
288.75/422.25) and 264.5 (IQR 171.75/422.25) counts, respectively (p = 0.01). The number 
of microemboli stayed higher (p ≤ 0.004) in the intervention group with CO2-gas, compared 
with the control group, when tested every minute during the experiment. In both groups, 
median values fell considerably between the first two minutes, with median values falling to 
12% (44.5/380.5, p < 0.01) in the control compared with 4% (9.5/264.5, p < 0.01) in the 
intervention group. Thereafter, between minute 2 and 13 in both groups, the number of 
microemboli declined gradually, with the lowermost values at the 13th minute, with median 
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counts of 7.5 in the control group versus 0 in the intervention group. The 14th minute showed 
the same pattern as the 1st, during which the oxygenator was once again tapped on 20 times. 
This resulted in a remarkable rise in number of microemboli versus the 13th minute (p < 
0.01).  The median values increased to 173 in the control group versus 87 in the intervention 
group. During the 15th minute the number of microemboli once again fell substantially in the 
two groups (p < 0.01), resulting in a median value of 15.5 in the control group versus 0.5 in 
the intervention group. These values corresponded to 9% in the control group and 0.5% in the 
intervention group of the values registered during the 14th minute. Those values corresponded 
to 35% (15.5/44.5) in the control group versus 5% (0.5/9.5) in the intervention group of the 
values during the 2nd minute.  
 
 
FIGURE 7. Median microembolic count for the intervention group (CO2-gas) and the control group (air) during 
the 15 minutes of the study. The perfusionist tapped on the oxygenator twenty times during the 1st and 14th 
minute (arrows), which resulted in an increase in number of gaseous microembolic counts. 
4.2 STUDY II 
In the wound model using the mini-diffuser the content of air at a depth of 15 mm was 0.5 ± 
0.2%, 0.5 ± 0.2%, 0.6 ± 0.3%, 0.6 ± 0.3%, and 1.5 ± 1.2% during continuous CO2-
insufflation of 2, 3, 4, 5, and 10 L/min, respectively. 40 mm below the edge of the wound 
cavity opening the related values were 0.8 ± 0.3%, 0.5 ± 0.2%, 0.4 ± 0.2%, 0.3 ± 0.2%, and 
0.2 ± 0.1%, respectively, Figure 8.  
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FIGURE 8. Measured content of air under stable conditions during inflow of CO2-gas when applying various 
flows in an experimental minimally invasive surgical wound cavity with the new mini-diffuser. The air 
concentration was assessed 15 mm and 40 mm beneath the edge of the wound cavity opening. 
 
Using the open-ended tube, the control device, to fill the experimental wound cavity with 
CO2-gas, the mean concentration of air was 10% - 20% at 2 and 3 L/min of CO2-gas, and the 
mean concentration of air augmented to 20% - 75% at CO2-flows of 4, 5 and 10 L/min, 
respectively,  
 
 
FIGURE 9. Measured content of air at steady state during CO2-insufflating at different flow rates in an 
experimental minimally invasive surgical wound cavity using an open-ended tube (inner diameter of 1 mm). 
The air concentration was determined 15 mm and 40 mm beneath the opening edge of the cavity. 
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Figure 9. Consequently, when compared with the control, the mini-diffuser displaced air in 
the experimental wound cavity substantially more effectively at all flows (p = 0.02). The 
mini-diffuser de-aired the experimental minimally invasive surgical wound cavity extremely 
efficiently, < 1% residual air, in contrast with the open-ended tube, > 40% residual air, Table 
2.  
 
TABLE 2. Summarizing comparison between the experimental results of the new device to the control.  
Insufflation device Open-ended tube 
(1 mm inner diameter) 
Mini-diffuser  
CO2-gas flow 5 L/min 10 L/min 5 L/min 10 L/min 
Mean air concentration in the 
experimental surgical wound cavity  
43% 49% < 1% < 1% 
 
Figure 10 illustrates the air concentration when applying a rough suction rate of 10 L/min for 
2 seconds. A minor significant increase in concentration of air happened after 5 seconds at 
every flow rate (p < 0.001). Thereafter, the concentration of air returned to stationary levels 
for all flows after ten seconds. Hence, despite a period of 2 seconds with rough suction rate of 
10 L/min the concentration of air stayed < 1% at every CO2-flow, with the exception of the 
low flow rate of 2 L/min. This flow rate increased the content of air to circa 2.4% (p < 0.001). 
Figure 11 depicts air concentration after a 2 second period of rough suction of 15 L/min. 
When a suction force of 10 L/min was added, the mean concentration of air in the cavity 
increased significantly after five seconds at every CO2-gas flow rate (p < 0.001). Conversely, 
the mean concentration of air merely rose over 1% at a CO2-flow of 2 and 10 L/min. The 
concentration of air reverted to stable levels for every CO2-flow in 10 seconds that was like 
when using a suction force of 10 L/min. The continuous use of a rough suction force of 5, 10, 
and 15 L/min, at a CO2-flow of 2, 3, 4, 5, and 10 L/min, respectively, caused an unambiguous 
outline. For each rise in CO2-gas flow rate the concentration of air diminished significantly (p 
< 0.001) for the 3 suction rates. The only exception was when we augmented the CO2-gas 
flow from 5 to 10 L/min, the content of air did not change statistically when applying a rough 
suction force of 5 L/min (p = 0.21). 
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FIGURE 10. Content of air measured every 5 seconds during CO2-gas insufflation with the new mini-diffuser and 
after applying a rough suction force of 10 L/min during the first two seconds. CO2-gas flow rates of 2, 3, 4, and 5 
L/min, respectively, were used in this setup. 
 
The mean concentration of air was ≤ 10% at a CO2-flow rate of 4, 5, and 10 L/min, 
respectively, with a uninterrupted rough suction force of 5 and 10 L/min, Figure 12. Using a 
CO2-flow of 10 L/min the concentration of air stayed beneath 10% when applying 
uninterrupted suction forces of 5, 10, and 15 L/min. The mean concentration of air in the 
minimally invasive cardiothoracic wound cavity of six patients, who underwent AVR, was 
0.4 ± 0.5% and 0.6 ± 0.7%, when delivering CO2-gas at a rate of 5 and 8 L/min, respectively, 
via the mini-diffuser.  
 
 
FIGURE 11. Content of air measured every 5 seconds during insufflation of CO2-gas with the new mini-diffuser 
and after applying a rough suction force of 15 L/min during the first two seconds. CO2-gas flow rates of 2, 3, 4, 
5, and 10 L/min, respectively, were used in this setup. 
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FIGURE 12. Air concentration at stable conditions when insufflating CO2-gas with the new mini-diffuser and 
when concomitantly applying uninterrupted a rough suction rate of 5, 10, and 15 L/min. CO2-gas flow rates of 
2, 3, 4, 5, and 10 L/min, respectively, were used in this setup. 
 
No patient had symptoms of postoperative cerebral or cardiac deterioration, Table 3. 
 
TABLE 3.  The essential results when applying the mini-diffuser in six adults undergoing minimally invasive 
aortic valve replacement. 
 
Mini-diffuser Postoperative 
stroke or 
cognitive 
dysfunction 
Decrease in 
regional right or 
left 
ventricular 
function after CPB 
Ventricular 
arrhythmias 
after CPB 
CO2-flow rate 5 L/min 8 L/min 0/6 0/6 0/6 
Mean air content 
in surgical cavity 
<1% <1% 
 
  
CPB = Cardio-pulmonary bypass 
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4.3 STUDY III  
Table 4 depicts patient characteristics. Eighty percent of the patients were men and the 
median age was 62 years (IQR: 54.25 - 64.5).  
TABLE 4. Patient characteristics  
Characteristic median (IQR) 
Age, years 62 (54.25-64.5) 
Female gender, no (%) 2 (20) 
Height, cm 179 (175 – 185) 
Weight, kg 80 (75 – 88) 
Body mass index, kg/m2 26.1 (22.8 – 29.3) 
Creatinine µmol/L 92 (83 – 102) 
eGFR, mL/min 66 (59 – 76) 
EuroSCORE II 1.08 (0.67 – 2.73) 
Diabetes Mellitus, no (%) 1 (10) 
CPB duration, min 90 (80 – 108) 
Aortic cross clamp, min 69 (65 – 90) 
Pump flow, L/min 4.70 (4.58 – 5.03) 
Abbreviations: CPB = Cardio-pulmonary bypass, eGFR = estimated glomerular filtration rate, was calculated using the 
Cockcroft-Gault formula. 
 
Median PaCO2 did not differ between the conventional and the interventional setups (5.41; 
IQR: 5.29 - 5.57, vs. 5.41; IQR: 5.24 - 5.58, p = 0.92), whereas median sweep gas flow 
(L/min) was significantly lower (2.58, IQR: 2.50 - 3.16 vs. 4.42, IQR: 4.00 - 5.40, p = 0.002) 
when CO2-gas was not drained from the additional to the standard reservoir, the 
interventional setup. All blood gas results from the three sampling points and the sweep gas 
flows during the interventional and conventional setups are presented in Table 5. 
 
TABLE 5. Results from separating collection of blood and gas from the open surgical wound during cardio-
pulmonary bypass with an additional cardiotomy reservoir during de-airing with CO2-gas insufflation 
Characteristic Use of additional separate 
venous reservoir 
Standard use of venous 
reservoir 
P-value 
PaCO2, kPa 5.41 (5.29 – 5.57) 5.41 (5.24 – 5.58) 0.92 
Arterial pH 7.35 (7.33 – 7.37) 7.36 (7.33 – 7.37) 0.39 
PvCO2, kPa 6.17 (5.92 – 6.44) 6.13 (6.00 – 6.55) 0.77 
Venous pH 7.33 (7.31 – 7.34) 7.32 (7.31 – 7.34) 0.87 
Pre-oxygenator PCO2, kPa 6.16 (5.91 – 6.31) 6.70 (6.28 – 7.00) 0.004 
Pre-oxygenator pH 7.33 (7.31 – 7.35) 7.30 (7.28 – 7.33) 0.008 
Sweep gas flow, L/min 2.58 (2.50 – 3.16) 4.42 (4.00 – 5.43) 0.002 
Variables are described as median (Interquartile range). Abbreviations:  PaCO2 = CO2 pressure in arterial blood. PvCO2 = CO2 
pressure in blood from the venous cannula draining blood from the vena cava.  Pre-oxygenator PCO2 = CO2 pressure in 
blood from the venous blood that passed the venous reservoir just before entering the oxygenator. 
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4.4 STUDY IV  
340 patients were screened from February 2007 to June 2008. 51 patients were randomized to 
either radial (n = 28) or femoral (n = 23) approach, respectively. Table 6 describes baseline 
characteristics. Every patient was on aspirin and patients in the radial group were given 5,000 
units of intravenous heparin at start of coronary angiography. 
TABLE 6. Patient characteristics  
Characteristic Angiography via 
Right Femoral 
Artery (n = 23) 
Angiography via 
Right Radial 
Artery (n = 20) 
P value 
Age, y, mean (SD) 66.3 (7.6) 61.6 (8.8) 0.08 
Female sex (%) 4 (17) 2 (10) 0.67 
Hypertension 16 (70) 12 (60) 0.51 
Diabetes mellitus 12 (52) 2 (10) 0.004 
Previous stroke/Transitory ischemic attack 4 (17) 2 (10) 0.68 
Previous acute myocardial infarction 3 (13) 4 (20) 0.68 
Previous percutaneous coronary intervention 3 (13) 4 (20) 0.69 
Number of coronary stenoses 
  
0.03 
No stenosis 5 (22) 12 (60) 
 
1-vessel disease 12 (52) 3 (15) 
 
2-vessel disease 4 (17) 2 (10) 
 
3-vessel disease 2 (9) 3 (15) 
 
Contrast volume (mL) 75 (60 - 100) 82.5 (50 - 160) 0.31 
Fluoroscopy time (min) 2.5 (1 - 5) 6 (2 - 12) <0.0001 
Number of gaseous microemboli 44 (7 - 131) 58 (19 - 469) 0.08 
Number of particulate microemboli 6 (1 - 19) 10 (1 - 120) 0.02 
Right middle cerebral artery 2 (0 - 9) 7 (1 - 65) 0.004 
Left middle cerebral artery 3 (0 - 15) 3 (0 - 55) 0.57 
Values are mean ± SD, numbers (%) or median (minimum–maximum range). 
 
We did not include eight patients in the analysis because of conversion from radial to femoral 
access. More patients in the radial group did not present pathological coronary arteries and 
had longer fluoroscopy durations. We identified cerebral microemboli in every patient.  
 
 
 
FIGURE 13. Number of particulate cerebral microemboli during coronary angiography. Mean ±SEM. 
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Most microemboli were gaseous, and predominately occurred during flushing of the 
catheters. However, number of gaseous microemboli differed insignificantly between the 
groups, Table 6. The median number of particulate microemboli was higher (67%) in the 
radial group (p = 0.02) compared with femoral group, Table 6 and Figure 13.  
 
FIGURE 14. Number of particulate cerebral microemboli during coronary angiography when split into 
procedural phases. Mean ± SEM; ns = non-significant. 
 
 
More particulate microemboli were registered during catheter exchanges than when the 
coronary arteries were examined in both groups (7 [range, 0 - 51] versus 1 [range, 0 - 67]; p < 
0.001). When the left and right MCA were separately analyzed, significantly more particulate 
microemboli circulated through the right MCA with the radial approach, Table 6, mostly 
during catheter exchanges, Figure 14. We did not detect any strokes. 
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5 DISCUSSION 
To minimize the occurrence of microemboli in cardiac surgery and coronary angiography 
several measures may be used. In the experimental Study I, it was shown that if an empty 
CPB circuit is insufflated with CO2-gas from the highest part of the venous reservoir at a flow 
of 10 L/min, > 99% of all air is evacuated within 3 - 4 minutes. Moreover, in the 
experimental and clinical Study II, efficient CO2 de-airing was accomplished with the mini-
diffuser, reaching < 1% residual air in an experimental minimally invasive cardiothoracic 
surgical wound cavity, whether applying an intermittent rough suction force or not, and in 
patients undergoing minimally invasive AVR. In the clinical cross-over Study III, it was 
shown that the use of an additional venous reservoir for evacuation of blood from the open 
cardiothoracic surgical wound cavity prevents CO2-insufflation induced hypercapnia, keeping 
PaCO2 and sweep gas flow stable. This prevents CO2 induced hyperperfusion of the brain and 
thus decreases the probability of cerebral embolization during CO2-gas de-airing in open 
cardiac surgery. Finally, the RCT, Study IV, indicated that the radial approach for coronary 
angiography produced a significantly higher number of particulate cerebral microemboli than 
the alternative femoral approach, and thus consequently may have an impact on the incidence 
of silent cerebral lesions. 
5.1 DE-AIRING OF A CPB CIRCUIT 
The aim of Study I was to ensure a high CO2-gas content in the CPB system as quickly as 
possible using conventional CPB setup. Subsequently, we applied a fixed high CO2-gas flow 
of 10 L/min and we limited the time of CO2-gas insufflation to 10 minutes. We detected that 
a sufficiently high CO2-concentration, more than 99.5%, had been achieved at all 3 
measuring sites of the CPB system within 4 minutes. Unexpectedly, the CO2-gas 
concentration rose significantly slower in the oxygenator than at the highest point of the 
venous reservoir and at the shunt. One may speculate about the reason for these differences. It 
may be caused by an irregular allocation of the CO2-gas in the hollow fibers of the 
oxygenator.  
Not many studies have investigated the presence of microemboli during the initiation of CPB. 
To our knowledge, the study by Bucerius et al. is the only previous clinical study in this field.  
Those authors reported a higher number of air emboli at the start of CPB.[3] Furthermore, an 
experimental study by Martens et al. showed that arterial CO2 microemboli disappeared 
significantly earlier than air bubbles, when entering a de-aired CPB system.[39] In Study I, 
when CPB-circuits containing air were recirculated for 15 minutes with prime fluid, 
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involving  2 minutes when the perfusionist tapped with a clamp on the oxygenator, proficient 
de-airing of the CPB circuit was not accomplished. A prolonged duration of re-circulation, 
and/or with an extended time of knocking may possibly have accomplished this, but that is 
still uncertain. Even if these measures were sufficient, it would still be more time consuming 
and more laborious. In contrast, the CPB-circuit was efficiently de-aired when insufflated 
with CO2-gas. 
5.2 CLINICAL CONSEQUENCES OF AIR EMBOLI 
One may debate whether rigorous de-airing of the primed CPB system is clinically relevant 
when starting CPB. However, previous studies have demonstrated that CO2-gas microemboli 
are considerably better abided compared with air microemboli.[29-32, 40, 41] Injection of air, 
0.5 mL/lb body weight, in the pulmonary vein in cats filled the cats’ coronary arteries with air 
and was fatal to all animals.[32] Conversely, the same volume of CO2-gas injected in the 
same manner was well tolerated in all cats. Even when a large volume of CO2-gas, 6 mL/lb 
body weight, which was 12 times the fatal volume of air, was injected, none of the cats died, 
though a temporary total occlusion of the coronaries with CO2-gas, was observed. These 
results clearly indicate that there is a remarkable difference in potential clinical outcomes 
between arterial air and CO2 emboli. Likewise, Borger et al. found that postoperative 
neurocognitive deficiency correlated directly with number of perfusionist interventions that 
caused arterial air microemboli.[34] 
5.3 DE-AIRING IN OPEN HEART SURGERY 
To prevent air embolism in standard open cardiac surgery, CO2-gas has for many years been 
insufflated in the open surgical wound cavity. However, almost two decades ago, 
conventional CO2-insufflation with an open-ended tube was found to be ineffective because it 
produced turbulence and thus poor de-airing of the open surgical wound due to the outgoing 
high velocity jet.[43] This study by Persson et al. demonstrated that effective de-airing of an 
open surgical wound cavity could only be accomplished with a gas-diffuser that allows a high 
CO2-gas outflow with a low velocity.[43] Additionally, to achieve efficient de-airing of the 
open surgical wound cavity the CO2-diffuser has to be positioned inside and not at the orifice 
or outside the open surgical wound cavity.[43] The gas-diffuser is nowadays applied in open 
heart surgery in most western countries according to its manufacturer (Cardia Innovation AB, 
Stockholm, Sweden).  
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5.3.1 De-airing in minimally invasive open heart surgery 
There is a need for a new small CO2-diffuser that does not interfere in minimally invasive 
open heart surgery. However, the new CO2-diffuser needs to be large enough to accomplish 
effective de-airing when used in a small open surgical wound cavity. The tested small gas-
diffuser was devised to fulfill those prerequisites, and in Study II we verified the mini-
diffusers effectiveness and also compared it with an alternative device, an open-ended tube, 
which may sometimes be applied in minimally invasive open heart surgery. We used an 
experimental setup to ensure that several variables known to have an impact on de-airing 
efficiency during cardiac surgery in an open wound could be altered, including wound cavity 
geometry, CO2-flow rates, and suction forces in the wound cavity when using a suction 
device.[68] We measured the wound size in adults undergoing minimally invasive AVR via a 
partial sternotomy wound to create an experimental wound cavity model.  
5.3.1.1 Influence of CO2-insufflation rate 
Continuous CO2-insufflation is a prerequisite to avert air from getting into the open heart and 
vessels, as else air confined in these cavities cannot easily be displaced. The CO2-insufflation 
flow was between 2 and 10 L/min. The lower flow rate should neutralize the impact of 
diffusion from ambient air, and the high flow rate is the advocated CO2-insufflation rate of 
the large diffuser when used in adult patients undergoing open heart procedures via a full 
sternotomy. Likewise, we determined the air concentration both at the bottom of the 
experimental cavity as well as near its orifice. This corresponds to the anterior part of the 
ascending aorta, where the force of diffusion from ambient air will be strongest.  
5.3.1.2 Influence of rough suction rate 
The intermittent application of a usually handheld suction device is an additional factor, 
which may have an impact on the efficacy of CO2 de-airing in open heart surgery. For this 
reason, we placed a rough suction device in the experimental minimally invasive wound 
cavity and utilized a suction force of either 5, 10, or 15 L/min where a bleeding from the 
artificial ascending aorta would most likely occur. De-airing using the open-ended tube 
caused an air content > 10% at a CO2-insufflation rate of 2 L/min and augmented markedly 
with every increase in CO2-gas insufflation rate. The resulting high concentrations of air were 
most likely due to turbulence produced by the high outflow velocity of the CO2-gas exiting 
the tiny opening of the open-ended tube. Conversely, with the new mini diffuser, de-airing of 
the experimental minimally invasive wound cavity produced an air concentration that stayed 
< 1% at CO2-insufflation flows between 2 and 5 L/min, and < 2% at a CO2-insufflation flow 
of 10 L/min. Using the mini-diffuser, CO2-insufflation rates between 3 and 5 L/min 
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minimizes the remaining air content, while the CO2-insufflation flow of 10 L/min minimizes 
the varying impact of the surgeon´s hand movements and different kinds of suction devices 
on de-airing efficiency.  
In cardiac surgery two different suction devices are usually applied. A device with a low 
suction rate, 0.25-1 L/min, is frequently used at the bottom of the cardiotomy for constant 
removal of blood. This suction device does not impede de-airing unless the suction force is 
approximately similar to or above the used CO2-gas flow. 
A high suction rate is intermittently applied with a rough suction device to evacuate blood 
from the operation field and to facilitate optimal surgical exposure without affecting CO2 de-
airing in standard cardiac surgery via a complete sternotomy.[68] When intermittently 
applying a rough suction rate of 10 L/min, the air concentration was < 1% at CO2-gas flows 
between 3 and 5 L/min in the experimental minimally invasive surgical wound cavity, while 
the concentration of air exceeded 2.5% at a CO2-gas flow of 2 L/min. An augmentation of the 
discontinuous suction rate to 15 L/min would have required an increased CO2-gas flow. 
Undeniably, using a discontinuous suction force of 15 L/min, the air concentration stayed < 
1% with CO2-insufflation flows of 4 to 5 L/min, and close to 1% at a CO2-gas flow of 10 
L/min. When applying a continuous rough suction force of 15 L/min in the experimental 
minimally invasive surgical wound cavity at CO2-gas flows of 2 to 5 L/min, the air 
concentration remained over 20%. With a CO2-insufflation flow of 10 L/min, the air 
concentration dropped below 7%. Consequently, when applying a continuous rough suction 
rate of 10 L/min in the experimental minimally invasive surgical wound cavity, the air 
concentration remained > 20% with a CO2-insufflation flow of 2 and 3 L/min, while with a 
CO2-insufflation flow of 4, 5, and 10 L/min the air concentration was below 10%. Thus, to 
prevent air confinement uninterrupted suction should be circumvented, particularly when the 
heart and large vessels are opened. The coronary suction devise will usually be applied with a 
substantially lower suction force for continuous suction of blood if profuse bleeding occurs, 
and will hence not influence de-airing. The mini-diffuser was also examined in patients 
undergoing minimally invasive AVR and the mini-diffuser de-aired the small open wound 
cavity effectively, with an air content < 1%, at an uninterrupted CO2-insufflation flow of both 
5 and 8 L/min. Accordingly, the high CO2-insufflation rate of 8 L/min should be applied 
when the surgical team anticipates to apply a rough suction device very often or for longer 
periods.  
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5.3.1.3 Does CO2 de-airing affect cerebral microembolization? 
A previous RCT in adults having conventional valve surgery via a complete sternotomy[12] 
and either receiving CO2-insufflation in the open surgical wound cavity via a conventional 
gas-diffuser, or not, number of microemboli in the left ventricle, left atrium and in the 
ascending aorta were estimated using intraoperative transesophageal echocardiography 
(TEE). Period of measurement began at the time-point of X-clamp release till 20 minutes 
after terminating CPB. The cardiac surgeon executed conventional de-airing movements 
while blinded to the TEE results. Later, a blinded evaluator compiled the maximal count of 
microemboli minute by minute. The median count of microemboli during the study was 161 
and 723 in the CO2-insufflation group and in the control group, respectively (p < 0.001). In 
the CO2-insufflation group, the estimated median microemboli count dropped to null seven 
minutes after end of CPB in contrast to 19 minutes in the control group (p < 0.001). The 
studied microemboli followed a typical pattern. Initially, the number of microemboli peaked 
immediately after the aortic cross-clamp had been released. Thereafter, the majority of 
microemboli whirled in the left ventricle and atrium without being ejected, and only few 
microemboli emerged in the ascending aorta. Another top emerged when the beating heart 
commenced to eject blood throughout weaning from CPB. During this stage, the majority of 
microemboli came from the pulmonary veins. The microemboli emerged as floating chaplets 
at the anterior wall of the left atrium, and subsequently circulated into the left ventricle, after 
which they appeared in the ascending aorta. Notwithstanding elaborate surgical de-airing 
maneuvers, new microemboli persisted to materialize in the left atrium until the end of the 
study period, 20 minutes after termination of CPB. The second peak of microemboli 
coincides with the findings of a previous TCD report during open heart surgery, where the 
majority of cerebral microemboli appeared during and after termination of CPB.[3]. This is 
the precarious time point, since it is during termination of CPB that the heart resumes to emit 
microemboli to the cerebral circulation. Hence, it is this time point when the distinction in the 
count of microemboli between patients given CO2-insufflation and controls becomes 
evident.[3] Likewise, one should take in consideration that in patients experiencing CO2-
insufflation, the number of microemboli were fewer and diverged in their composition from 
those in the control group.[12] They contained CO2-gas and not air. 
5.3.1.4 How to eliminate CO2-insufflation induced hypercapnia in open heart surgery  
In Study III we used an additional cardiotomy suction device at a constant suction rate of 1 
L/min as the coronary suction device suction rate may vary between 0.25 - 1 L/min and as the 
latter device is sometimes held outside the wound cavity. In this way, CO2-gas was 
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continuously drained to the additional cardiotomy reservoir followed by drainage to the 
conventional cardiotomy reservoir, where CO2-gas was quickly absorbed in the circulating 
venous blood. As a consequence, the impact of CO2-gas on PaCO2 in the conventional setup 
was manifest resulting in increased sweep gas flows in order to keep normocapnia. 
Importantly, the conventional setup functionally corresponds to standard practice using a 
setup without an additional venous reservoir. 
In contrast, during the interventional setup, CO2-gas could not be drained from the additional 
to the standard venous reservoir and could thus not be absorbed by circulating venous blood 
in the standard venous reservoir. This resulted in a mean sweep gas flow of 2.6 L/min 
compared with 4.4 L/min in the conventional group, which was approximately 40% higher. 
Extrapolating these data to clinical practice, the use of an additional venous reservoir, with a 
clamped connection to the standard venous reservoir, for suction of gas and blood from the 
surgical wound cavity during de-airing with CO2-gas insufflation prevents fluctuation of 
PaCO2 levels and the need of changing sweep gas flows according to the amount of CO2-gas 
being evacuated to the venous reservoir. It may also in this setup be difficult to achieve 
normocapnia in very large patients where the capacity of the oxygenator to remove CO2 is 
reaching its limitation when very high sweep gas flows are needed. Moreover, as the amount 
of CO2-gas entering the standard cardiotomy reservoir during clinical practice may vary due 
to the used coronary suction rate and if the coronary suction device is held within the wound 
or not, PaCO2 may still fluctuate if a fixed increased sweep gas flow rate is used. Only the 
interventional setup can prevent this from happening, avoiding changes in the arterial 
pressure of carbon dioxide (PaCO2) dependent cerebral perfusion. Furthermore, use of on-
line arterial blood gas monitoring may not prevent but only mitigate fluctuations in PaCO2 
during de-airing with CO2-insufflation.  
5.4 MINIMIZING CEREBRAL MICROEMBOLISM IN CORONARY ANGIO-
GRAPHY 
Study IV, a RCT, demonstrated that cerebral microemboli emerged during coronary 
angiography in every patient with the femoral as well as the right radial access. However, the 
right radial access produced significantly more particulate microemboli than the femoral 
approach, and these findings are in agreement with a previous non-randomized study.[4] 
With the right radial approach, particulate microemboli occurred more frequently in the right 
than the left MCA, particularly when catheters were exchanged, in contrast to the femoral 
approach. Particulate microemboli are probably more harmful as one may expect them to 
permanently block small cerebral arteries and arterioles. When using the right radial access, 
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the catheters used for angiography need to be pushed past the orifice of the right 
brachiocephalic artery and be distinctly curved into the ascending aorta. This protruding 
movement might dislocate atherosclerotic plaques from the arterial wall with the risk of 
ensuing embolization. Furthermore, due to the longer period of angiography using the radial 
approach, the angiography catheters may themselves compose an extra source of emboli. 
Study IV thus advocates the use of a single catheter. Moreover, in patients with vascular 
dementia diffusion-weighted MRI studies suggest that small clinically silent defects may 
promote to neuropsychological decline.[69] Prospective reports using diffusion-weighted 
MRI have revealed new silent ischemic cerebral defects following cardiac catheterization, 
with a rate of 5% to 22%[4-6, 70, 71] and cerebral particulate microemboli were confirmed 
using TCD in three of the studies.[4-6] Additionally, in one of the reports cognitive tests 
suggested a causal relationship between microemboli and neuropsychological deficiency,[4] 
indicating that the findings of Study IV are of clinical relevance. 
5.5 CLINICAL IMPLICATIONS 
Study I indicates that to minimize microemboli in the CPB prime the perfusionist should 
insufflate CO2-gas into the empty CPB circuit from the highest point of the venous reservoir 
for 3 - 4 minutes and then recirculate the prime fluid for 15 minutes as well as to tap on the 
oxygenator for 2 minutes. Those precautions are easy to perform, will minimize the de-airing 
procedure, are cheap, and will protect the patients from air microembolization. However, if 
CO2-insufflation is not used, the perfusionist’s maneuvers, including 15 minutes of re-
circulating the CPB system with prime fluid, including 2 minutes of tapping on the 
oxygenator, will fail to de-air the CPB system, and may increase the risk of adverse clinical 
events.  
Study II demonstrates that the mini-diffuser can be used clinically for efficient CO2 de-airing 
in minimally invasive open heart surgery also when normal types of suction devices are 
applied. 
Study III shows that the simple use of an additional venous reservoir for evacuation of blood 
and gas from the open surgical wound eliminates possible hypercapnia induced by CO2-
insufflation in open heart surgery and thus keeps PaCO2 and sweep gas flow constant. In this 
way, hyperperfusion of the brain induced by CO2-insufflation for de-airing in open heart 
surgery is prevented and the risk of particulate cerebral microembolization is decreased. 
Study IV advocates the use of a single angiography catheter to minimize cerebral 
microembolization. As the right radial approach produced more particulate microemboli to 
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the brain than the femoral approach one may consider using the latter in patients with severe 
arteriosclerosis of the thoracic aorta. 
5.6 LIMITATIONS 
There are some limitations in Study I. First, a pre-bypass filter was not applied. Such a filter 
is sometimes omitted in clinical practice and, even if it had been used, it could not prevent the 
release of air microemboli from the oxygenator. The Hatteland bubble detector that was 
applied in Study I has the drawback that it cannot identify small bubbles with a diameter less 
than 10 μm. Nevertheless, as far as we know, such small air microemboli have never been 
identified to be of any physiological or clinical importance.  
In Study II most measurements were performed in an experimental cavity preventing 
comprehensive testing of the mini-diffuser at various set-ups in patients. It would have been 
unethical to undertake all these different measurements in patients, as this would have 
considerably prolonged the duration on CPB. Moreover, in the few patients undergoing 
minimally invasive AVR where we actually performed single measurements, we did not 
evaluate the possible consequence on neuropsychological function using continuous CO2 
insufflation for prevention of air microembolism. Effective de-airing with CO2-gas of the 
minimally invasive surgical wound cavity should inhibit air from getting into the open heart 
and great vessels, and consequently prevent air microemboli from entering the arterial 
circulation.  
A limitation of Study III is that the number of patients was very limited, only ten patients. 
However, the patients were used as their own controls and the differences were highly 
significant both statistically and in numbers indicating that the number of patients was 
sufficient and that the results have a clinical impact. Moreover, we did not use a dual 
chamber cardiotomy reservoir that is commercially available (Sorin Inspire HVR Dual, Sorin 
Group Italia S.r.l. Mirandola (MO), Italy) because the wall separating the two chambers is 
open at its upper part allowing for gas exchange. Instead we used an additional venous 
reservoir connected to the standard venous reservoir via a tube enabling the possibility to 
separate the content of the reservoirs by clamping the connecting tube. It may also be argued 
that the occasional drainage of blood from the additional to the standard venous reservoir in 
the interventional group may have influenced outcome values. However, it can be presumed 
that the absorption of CO2-gas into the gas-blood interface of blood in the additional venous 
reservoir will very quickly be reduced as the surface blood is stagnant and the volume is 
relatively small compared with the standard setup where CO2-gas will interfere with a large 
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blood surface area that is constantly exchanged with a blood flow of 4.6 L/min. Our data 
indicate that this presumption was correct. 
There are several limitations in Study IV. There was a high crossover rate from radial to 
femoral access. Those patients were not included in the analysis. Also, the coronary 
angiographers, who were experienced with both approaches, preferred to alter access site 
rather than using additional catheters, as indicated by the low number of additional catheters 
used. Furthermore, most cerebral microemboli were detected during maneuvers, which were 
rather independent of the skill of the coronary angiographer, including catheter insertions and 
exchanges. The duration of fluoroscopy with the radial approach exceeded that of the femoral 
approach, indicating a potential confounding factor caused by longer duration of contact 
between the catheters and the arterial vessel walls. Even though the difference in fluoroscopy 
time between the access sites has dropped over the years, the radial access is linked to a 
longer exposure of radiation.[49, 50] The relation between the higher cerebral microembolic 
rate and the radial access is supported by the finding of fewer cerebral microemboli in the 
femoral group, notwithstanding the higher risk factors for stroke with the femoral access, 
including absence of additional heparin use, rate of diabetes mellitus and severe coronary 
artery disease. 
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6 CONCLUSIONS 
The specific conclusions were: 
• CO2-insufflation of an empty CPB circuit reduces the number of gaseous emboli in 
the prime compared with a conventional CPB circuit, which contains air before fluid  
priming.  
 
• More than 99% of air is displaced within 3 to 4 minutes of re-circulation with CO2-
gas at a flow rate of 10 L/min, if the empty CPB circuit is insufflated from the highest 
part of the venous reservoir. Knocking on the oxygenator releases gaseous emboli. 
Duration of re-circulating the CPB circuit with fluid prime reduces the number of 
microemboli, and 15 minutes of re-circulation is efficient.  
 
• The mini-diffuser was effective for CO2 de-airing, with < 1% remaining air, in a 
minimally invasive open cardiothoracic wound cavity model with and without 
intermittent rough suction and in patients undergoing minimally invasive aortic valve 
surgery. 
 
• An additional venous reservoir, with a clamped connecting tube to the standard 
venous reservoir, for evacuation of gas and blood from the open surgical wound 
eliminates CO2-insufflation induced hypercapnia in open heart surgery keeping 
PaCO2 and sweep gas flow constant. 
 
• For coronary angiography, the radial access site generates more particulate cerebral 
microemboli than the femoral access site. 
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